Evidence map›Paper›PMID 35422113›Full record

ArticleScientific reports2022

Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis.

Dipanjan Ghosh, Debabrata Ghosh Dastidar, Kamalesh Roy, Arnab Ghosh, Debanjan Mukhopadhyay, Nilabja Sikdar, Nidhan K Biswas, Gopal Chakrabarti, Amlan Das

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Heliyon · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Dipanjan Ghosh *Department of Biotechnology, Dr. B. C. Guha Centre for Genetic Engineering and Biotechnology, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, West Bengal, 700019, India.
Debabrata Ghosh Dastidar *Guru Nanak Institute of Pharmaceutical Science and Technology, 157/F Nilgunj Road, Panihati, Kolkata, West Bengal, 700114, India.
Kamalesh Roy *Department of Genetics, Institute of Genetic Engineering, 30, Thakurhat Road, Badu, Madhyamgram, West Bengal, 700128, India.
Arnab GhoshNational Institute of Biomedical Genomics, PO NSS, Kalyani, West Bengal, 741251, India.
Debanjan MukhopadhyayNational Institute of Biomedical Genomics, PO NSS, Kalyani, West Bengal, 741251, India.
Nilabja SikdarHuman Genetics Unit, Kolmogorov Bhaban, Biological Sciences Division, Indian Statistical Institute, 203, BT road, Kolkata, West Bengal, 700108, India. snilabja@gmail.com.
Nidhan K BiswasNational Institute of Biomedical Genomics, PO NSS, Kalyani, West Bengal, 741251, India.
Gopal ChakrabartiDepartment of Biotechnology, Dr. B. C. Guha Centre for Genetic Engineering and Biotechnology, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, West Bengal, 700019, India. gcbcg@caluniv.ac.in.
Amlan DasNational Institute of Biomedical Genomics, PO NSS, Kalyani, West Bengal, 741251, India. ad4@nibmg.ac.in.
National Institute of Biomedical Genomics · INUniversity of Calcutta · INIndian Statistical Institute · INNational Institute of Pharmaceutical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently published clinical data from COVID-19 patients indicated that statin therapy is associated with a better clinical outcome and a significant reduction in the risk of mortality. In this study by computational analysis, we have aimed to predict the possible mechanism of the statin group of drugs by which they can inhibit SARS-CoV-2 pathogenesis. Blind docking of the critical structural and functional proteins of SARS-CoV-2 like RNA-dependent RNA polymerase, M-protease of 3-CL-Pro, Helicase, and the Spike proteins ( wild type and mutants from different VOCs) were performed using the Schrodinger docking tool. We observed that fluvastatin and pitavastatin showed fair, binding affinities to RNA polymerase and 3-CL-Pro, whereas fluvastatin showed the strongest binding affinity to the helicase. Fluvastatin also showed the highest affinity for the Spike

Indexed as

COVID-19 Drug TreatmentHydroxymethylglutaryl-CoA Reductase InhibitorsAntiviral AgentsFluvastatinHumansMolecular Docking SimulationMolecular Dynamics SimulationSARS-CoV-2Antiviral AgentsFluvastatinHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID35422113
PMCPMC9009757
OpenAlexW4225991078

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.